Gold dropped on vaccine rollout
XAU/USD has been falling due to market optimism. Will it keep moving down?
What happened?
First of all, the FDA approved the vaccine of Pfizer and BioNTech for emergency use. That’s why the market sentiment improved, and investors streamed their capital to riskier currencies and stocks. Elsewhere, the EU and the UK agreed to continue negotiating, giving a signal that the deal may be reached soon. The prospect for the Brexit agreement added to the risk-on sentiment as well. Even hopes for the additional US stimulus package and the massive USD selloff haven’t helped gold to rise.
Technical tips
XAU/USD is moving inside the descending channel. It is approaching the key support of the 200-day moving average of $1 810. Gold is unlikely to break it down for the first attempt. That’s why we can expect it will bounce off this level initially. If it manages to break it down, it may drop to the next support at the low of November 30 at $1 770. On the flip side, the move above the recent highs of $1 845 will drive XAU/USD to the 50-period moving average of $1 870, which it has failed to cross several times. In a nutshell, gold is stuck between two moving averages.
